Concepedia

Elisabeth Narayanan

EN

Statistics

Publications

14

Citations

2.7K

H-Index

14

Active since

2012

Affiliations

Moderna Therapeutics (United States)(Current)

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Vanderbilt University Medical Center

Frederick National Laboratory for Cancer Research

Elisabeth Narayanan is an author at Moderna Therapeutics (United States) specializing in immunology, vaccinology, and viral vaccines.

ORCID

Publications per year

2012–2024

14

Publications

14

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · Nature · 2020 · 1.7K citations · Full text

, , +14

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection

Nurgun Kose, Julie M. Fox, Gopal Sapparapu et al. · Science Immunology · 2019 · 207 citations

, , +17

A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

Peng Zhang, Elisabeth Narayanan, Qingbo Liu et al. · Nature Medicine · 2021 · 165 citations

, , +14

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 143 citations · Full text

, , +17

Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA

Mark Cornebise, Elisabeth Narayanan, Yan Xia et al. · Advanced Functional Materials · 2021 · 123 citations · Full text

, , +17

1–5 of 14